Catch-Up Report — October 21, 2026 Development
Danaher raised its full-year adjusted earnings forecast on October 21 after reporting third-quarter revenue of $6.6 billion, an 8.5% increase from a year earlier, according to its earnings release filed with the Securities and Exchange Commission.
The life sciences and diagnostics company reported $1.2 billion in earnings from continuing operations for the quarter ended September 25. Diluted earnings per share from continuing operations rose 34.5% to $1.71. Adjusted diluted earnings per share increased 11.5% to $2.11.
Danaher’s core revenue measure rose 3%. Excluding respiratory revenue, that growth measure was 5.5%. Core revenue and adjusted earnings are non-GAAP measures, distinct from the company’s reported accounting results.
The company increased its 2026 adjusted diluted earnings forecast to $8.57–$8.62 per share, from $8.45–$8.60. It expects approximately 3% core revenue growth in the fourth quarter, with respiratory revenue weighing on the comparison.
The outlook represents management’s expectations rather than completed results. The company said uncertainty about several future adjustments prevents a full reconciliation of its forecast to GAAP measures.
Sources Danaher earnings release filed with the SEC: https://www.sec.gov/Archives/edgar/data/313616/000031361626000201/dhr-20261021xex991.htm